Document Detail

Counteracting autophagy overcomes resistance to everolimus in mantle cell lymphoma.
MedLine Citation:
PMID:  22879389     Owner:  NLM     Status:  Publisher    
PURPOSE: Mantle cell lymphoma (MCL) is an aggressive B-lymphoid neoplasm with poor response to conventional chemotherapy and short survival. The phosphatidylinositol 3-kinase/Akt/mTOR survival pathway is constitutively activated in MCL cells, thereby making the mTOR inhibition an attractive therapeutic strategy. The first clinical studies of everolimus (RAD001), an mTOR inhibitor, in relapsed MCL patients have reported a significant response. Our aim was to analyze the mechanism related to everolimus resistance/sensitivity in MCL cells. EXPERIMENTAL DESIGN: Sensitivity to everolimus was analyzed in MCL cell lines and primary MCL cells. Everolimus mechanism of action was determined by flow cytometry, and western blot. Particularly, autophagy was studied by LC3BI/II expression, autophagolysosomes detection by flow cytometry and fluorescence microscopy, and siRNA-mediated gene silencing. RESULTS: Everolimus exerted antitumoral effect on MCL cells while sparing normal cells. In MCL cell lines this phenomenon was associated to G1 cell-cycle arrest, dephosphorylation of the mTOR downstream targets, 4E-BP1 and S6RP, and rephosphorylation of Akt. A synergistic cytotoxic effect was observed between everolimus and an Akt inhibitor, which overcame the compensatory reactivation within the mTOR signaling pathway. Interestingly, MCL cells with low response to this combination showed high levels of autophagy. Accordingly, selective triple knockdown of the autophagy genes ATG7, ATG5 and ATG3, and pre-treatment with the autophagy inhibitor hydroxychloroquine efficiently overcame the resistance to Akt/mTOR inhibitors, leading to the activation of the mitochondrial apoptotic pathway. CONCLUSIONS: These results suggest that autophagy induction protects MCL cells from Akt/mTOR targeting and counteracting autophagy may represent an attractive strategy for sensitizing MCL cells to everolimus-based therapy.
Laia Rosich; Silvia Xargay-Torrent; Monica Lopez-Guerra; Elias Campo; Dolors Colomer; Gael Roue
Related Documents :
16209129 - Height changes associated with pigment aggregation in xenopus laevis melanophores.
14985429 - Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pat...
1706999 - De novo formation of cytokeratin filaments in calf lens cells and cytoplasts after tran...
22293659 - Treatment with the parp-inhibitor pj34 causes enhanced doxorubicin-mediated cell death ...
25482939 - Hdac6 regulates neuroblastoma cell migration and may play a role in the invasion process.
21428939 - Exosome target cell selection and the importance of exosomal tetraspanins: a hypothesis.
19438409 - Interaction of anion exchanger 1 and glycophorin a in human erythroleukaemic k562 cells.
8037729 - Receptor-specific uptake and degradation of acetylated, oxidized and native ldl in the ...
19348949 - A new epigenetic marker: the replication-coupled, cell cycle-dependent, dual modificati...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-9
Journal Detail:
Title:  Clinical cancer research : an official journal of the American Association for Cancer Research     Volume:  -     ISSN:  1078-0432     ISO Abbreviation:  Clin. Cancer Res.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9502500     Medline TA:  Clin Cancer Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Hemato-oncology, IDIBAPS.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  EWS-FLI-1-targeted cytotoxic T-cell killing of multiple tumor types belonging to the Ewing sarcoma f...
Next Document:  Two new large deletions of the AVPR2 gene causing nephrogenic diabetes insipidus and a review of pre...